S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
NASDAQ:HOLX

Hologic (HOLX) Stock Price, News & Analysis

$77.33
-0.45 (-0.58%)
(As of 04/12/2024 ET)
Today's Range
$76.87
$77.82
50-Day Range
$72.04
$78.41
52-Week Range
$64.02
$87.88
Volume
1.55 million shs
Average Volume
1.82 million shs
Market Capitalization
$18.15 billion
P/E Ratio
36.65
Dividend Yield
N/A
Price Target
$87.00

Hologic MarketRank™ Stock Analysis

Analyst Rating
Hold
2.44 Rating Score
Upside/​Downside
12.5% Upside
$87.00 Price Target
Short Interest
Healthy
1.92% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.69
Upright™ Environmental Score
News Sentiment
0.59mentions of Hologic in the last 14 days
Based on 11 Articles This Week
Insider Trading
Selling Shares
$2.47 M Sold Last Quarter
Proj. Earnings Growth
8.46%
From $4.02 to $4.36 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.76 out of 5 stars

Medical Sector

145th out of 2,784 stocks

X - Ray Apparatus & Tubes Industry

1st out of 12 stocks

HOLX stock logo

About Hologic Stock (NASDAQ:HOLX)

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

HOLX Stock Price History

HOLX Stock News Headlines

Gold Hits New All-Time Highs
Due to both domestic and global issues, the trajectory of this precious metal could skyrocket in the coming months… Which is why billionaires and Central Banks alike are scooping up gold at record rates!
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Hologic (NASDAQ:HOLX) Upgraded to Buy at Citigroup
The Analyst Landscape: 4 Takes On Hologic
Hologic to Unveil Groundbreaking AI Research at ECR 2024
Hologic to Unveil Groundbreaking AI Research at ECR 2024
See More Headlines
Receive HOLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hologic and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/01/2024
Today
4/12/2024
Next Earnings (Confirmed)
5/02/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
X - ray apparatus & tubes
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:HOLX
CUSIP
43644010
Employees
6,990
Year Founded
1985

Price Target and Rating

Average Stock Price Target
$87.00
High Stock Price Target
$105.00
Low Stock Price Target
$72.00
Potential Upside/Downside
+12.1%
Consensus Rating
Hold
Rating Score (0-4)
2.44
Research Coverage
9 Analysts

Profitability

Net Income
$456 million
Pretax Margin
15.83%

Debt

Sales & Book Value

Annual Sales
$4.03 billion
Cash Flow
$5.34 per share
Book Value
$20.48 per share

Miscellaneous

Free Float
230,624,000
Market Cap
$18.22 billion
Optionable
Optionable
Beta
1.00

Social Links

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Should I Buy Hologic Stock? HOLX Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Hologic, Inc.:

  • Hologic, Inc. offers a diverse range of diagnostics products, medical imaging systems, and surgical products for women's health, catering to a specialized market segment with high demand.
  • The company provides innovative Aptima molecular diagnostic assays for detecting various infectious microorganisms, which can be crucial for early detection and treatment, enhancing its competitive edge.
  • Hologic's ThinPrep System for cytology applications and Rapid Fetal Fibronectin Test are cutting-edge solutions that assist healthcare professionals in critical assessments, potentially driving revenue growth.
  • Recent advancements in Hologic's breast cancer care solutions, including 3D digital mammography systems and minimally invasive breast biopsy guidance systems, showcase the company's commitment to technological progress and patient care.
  • Investors may find the current stock price of Hologic, Inc. attractive, considering the company's strong market presence and potential for future growth in the health care equipment industry.

Cons

Investors should be bearish about investing in Hologic, Inc. for these reasons:

  • Market competition in the health care equipment industry is intense, which could pose challenges for Hologic in maintaining its market share and profitability.
  • Regulatory changes or uncertainties in the healthcare sector may impact Hologic's operations and financial performance, leading to potential risks for investors.
  • Fluctuations in demand for medical imaging systems and surgical products, influenced by economic conditions or healthcare trends, could affect Hologic's revenue streams and stock performance.
  • Investing in a company focused on women's health may carry specific risks related to changing demographics, healthcare policies, or public perception, which investors need to consider.
  • While Hologic has a strong product portfolio, any delays or setbacks in product development or regulatory approvals could hinder the company's growth prospects and stock value.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, April 10, 2024. Please send any questions or comments about these Hologic pros and cons to contact@marketbeat.com.

HOLX Stock Analysis - Frequently Asked Questions

Should I buy or sell Hologic stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hologic in the last year. There are currently 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" HOLX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HOLX, but not buy additional shares or sell existing shares.
View HOLX analyst ratings
or view top-rated stocks.

What is Hologic's stock price target for 2024?

9 Wall Street analysts have issued 12 month target prices for Hologic's shares. Their HOLX share price targets range from $72.00 to $105.00. On average, they predict the company's stock price to reach $87.00 in the next twelve months. This suggests a possible upside of 12.5% from the stock's current price.
View analysts price targets for HOLX
or view top-rated stocks among Wall Street analysts.

How have HOLX shares performed in 2024?

Hologic's stock was trading at $71.45 on January 1st, 2024. Since then, HOLX shares have increased by 8.2% and is now trading at $77.33.
View the best growth stocks for 2024 here
.

When is Hologic's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our HOLX earnings forecast
.

How can I listen to Hologic's earnings call?

Hologic will be holding an earnings conference call on Thursday, May 2nd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Hologic's earnings last quarter?

Hologic, Inc. (NASDAQ:HOLX) released its earnings results on Thursday, February, 1st. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.95 by $0.03. The medical equipment provider earned $1.01 billion during the quarter, compared to analyst estimates of $989.32 million. Hologic had a trailing twelve-month return on equity of 18.91% and a net margin of 12.98%. Hologic's revenue was down 5.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.07 EPS.
Read the conference call transcript
.

What guidance has Hologic issued on next quarter's earnings?

Hologic issued an update on its FY 2024 earnings guidance on Thursday, February, 1st. The company provided EPS guidance of 3.970-4.120 for the period, compared to the consensus estimate of 4.000. The company issued revenue guidance of $4.0 billion-$4.1 billion, compared to the consensus revenue estimate of $4.0 billion.

What is Steve MacMillan's approval rating as Hologic's CEO?

447 employees have rated Hologic Chief Executive Officer Steve MacMillan on Glassdoor.com. Steve MacMillan has an approval rating of 79% among the company's employees. 81.0% of employees surveyed would recommend working at Hologic to a friend.

What other stocks do shareholders of Hologic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hologic investors own include AbbVie (ABBV), NVIDIA (NVDA), Johnson & Johnson (JNJ), Alibaba Group (BABA), Walt Disney (DIS), PayPal (PYPL), Advanced Micro Devices (AMD), CVS Health (CVS), Pfizer (PFE) and Abbott Laboratories (ABT).

Who are Hologic's major shareholders?

Hologic's stock is owned by a variety of institutional and retail investors. Top institutional investors include Congress Asset Management Co. MA (0.53%), Atwood & Palmer Inc. (0.15%), Perpetual Ltd (0.05%), Czech National Bank (0.02%), Banque Cantonale Vaudoise (0.01%) and First Hawaiian Bank (0.01%). Insiders that own company stock include Benjamin Jordan Cohn, Charles J Dockendorff, Essex D Mitchell, Jan Verstreken, John M Griffin, Karleen Marie Oberton, Scott T Garrett, Sean S Daugherty and Sean S Daugherty.
View institutional ownership trends
.

How do I buy shares of Hologic?

Shares of HOLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Hologic have any subsidiaries?
The following companies are subsidiares of Hologic: Acessa Health, Acessa Health Inc., Beijing Hologic Technology Co. Ltd., Benassar Diagnostica-Equipamientos Medicos Unipessoal Lda., BioLucent, BioLucent LLC, Bioptics Inc., Biotheranostics Inc, Biotheranostics Inc., Bolder Surgical, Cynosure, Cytyc, Cytyc Corporation, Cytyc Prenatal Products Corp., Cytyc Surgical Products LLC, Diagenode Co. Ltd., Diagenode LLC, Diagenode SA, Diagenode SA., Diagenode SPA, Direct Radiography Corp., Emsor Sociedad de responsabilidad limitada, Faxitron Bioptics, Faxitron Bioptics LLC, Focal Therapeutics, Gen-Probe, Gen-Probe Incorporated, Gen-Probe Prodesse Inc., Gen-Probe Sales & Service Inc., Genewave SAS, Health Beacons Inc, Health Beacons Inc., Hologic (Australia & New Zealand) Pty Ltd., Hologic (MA) LLC, Hologic (Shanghai) Medical Supplies Co. Ltd., Hologic ASE LLC, Hologic Asia Limited, Hologic Asia Pacific Limited, Hologic Austria GmbH, Hologic BV, Hologic Bermuda Limited, Hologic Canada ULC, Hologic Caribbean (Barbados) SRL, Hologic Denmark ApS, Hologic Deutschland GmbH, Hologic Espana S.A., Hologic Finance Ltd., Hologic France SARL, Hologic GGO 2 LLC, Hologic GGO 3 LLP, Hologic GGO 4 LTD, Hologic Global Holding LTD, Hologic HUB LTD, Hologic Hitec-Imaging, Hologic Hitec-Imaging GmbH, Hologic Holdings Limited, Hologic IP LTD, Hologic Iberia S.L., Hologic India LLP, Hologic International Holdings B.V., Hologic Ireland Limited, Hologic Italia S.r.l., Hologic Japan KK, Hologic Latin America (Servicos Em Marketing E Negocios) Ltda., Hologic Ltd., Hologic Malaysia SDN. BHD., Hologic Medical Technologies (Beijing) Co. Ltd., Hologic Medicor GmbH, Hologic Medicor Suisse GmbH, Hologic Netherlands B.V., Hologic Nordic Holdings Oy, Hologic Singapore Pte. Ltd, Hologic Suisse SA, Hologic Surgical Products Costa Rica S.R.L., Hologic Sweden AB, Hologic Taiwan Ltd., Hologic UK Finance Ltd., Hologic US Finance Co LLC, Interlace Medical, Mobidiag Oy, Mobidiag Oy., Mobidiag UK Ltd., NXT-Dx SCRL, Navigation Three Limited, R2 Technology, Sentinelle Medical, Somatex (HK) Limited, Somatex Medical Technologies GmbH, Somatex Medical Technologies GmbH., Somatex USA Inc., SuperSonic Imagine (Shanghai) Medical Devices Co. Ltd., SuperSonic Imagine GmbH, SuperSonic Imagine HK Ltd, SuperSonic Imagine Ltd, SuperSonic Imagine SA, SuperSonic Imagine Srl, Suros Surgical Systems, Suros Surgical Systems Inc., TCT International, TCT International Co. Ltd., Third Wave Technologies, and Tridaho LLC.
Read More
This page (NASDAQ:HOLX) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners